Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Scientific: Debora Spar, Patrick Durbin, Gianluca Pettiti

Debora Spar has been elected as a director of Thermo Fisher Scientific. She is a professor of business administration at Harvard Business School. Previously, she was president and CEO of Lincoln Center for the Performing Arts and before that, president of Barnard College. Spar holds a PhD in government from Harvard University and a BSc from Georgetown University.

Also, Patrick Durbin, senior vice president at Thermo Fisher Scientific, has decided to leave the company, effective Oct. 1. He will be replaced by Gianluca Pettiti, president of the firm's biosciences business. Prior to that, Pettiti was president of Thermo Fisher China.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.